| Literature DB >> 18093904 |
Fenne Verhoeven1, Lisette van Gemert-Pijnen, Karin Dijkstra, Nicol Nijland, Erwin Seydel, Michaël Steehouder.
Abstract
BACKGROUND: A systematic literature review was carried out to study the benefits of teleconsultation and videoconferencing on the multifaceted process of diabetes care. Previous reviews focused primarily on usability of technology and considered mainly one-sided interventions.Entities:
Mesh:
Year: 2007 PMID: 18093904 PMCID: PMC2270420 DOI: 10.2196/jmir.9.5.e37
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Checklist to classify the outcome measures related to the levels of diabetes care
| Level of Diabetes Care | Outcome Measures |
| Clinical | Improved clinical values (eg, dietary values, HbA1c , blood pressure) Improved quality of life (social functioning, general or mental health, well-being, and satisfaction with care) |
| Behavioral | Improved interaction (communication between caregivers and patients or among caregivers or patients themselves) Improved self-care (ablity to control diabetes and to cope with diabetes via self-monitoring, education, knowledge about diabetes, and personal feedback) |
| Care coordination | Improved usability (and adoption) of technology Reduction of costs (saving patients’ or caregivers’ time and reducing the use of health care services) Improved transparency (care delivery based on standards as guidelines, protocols for information exchange) Improved equity (the availability of health care to everyone) |
Checklist to categorize level of evidence of study design
| Level of Evidence | Study Design |
| 1 | Experimental studies (eg, RCT with blinded allocation) |
| 2 | Quasi-experimental studies (eg, experimental study with randomization) |
| 3 | Controlled observational studies |
| 3a | Cohort studies |
| 3b | Case control studies |
| 4 | Observational studies without control groups |
| 5 | Expert opinion based on bench research or consensus |
Figure 1.Study selection process
Overview of teleconsultation interventions (see Multimedia Appendix for full tables containing inclusion criteria and data gathering methods)
| Reference, Country, Year, and Duration of Intervention | Care Setting and Intervention | Study Design | Reported Findings (Improvements) * |
| [ Italy/Spain/Norway 2002 18 months, follow-up planned (duration unknown) | Secondary care. | Observational studies without control group: n = 32 Four conditions: Verification phase: clinical evaluation (n = 3) Pilot clinical validation (n = 12) Demonstration phase: Intranet (n = 6) Demonstration phase: Internet (n = 11) | |
| [ Italy/Spain/Germany 2003 12 months, follow-up unknown | Integrated care. | Experimental studies (RCT): n = 106 Two conditions: Intervention: n = 56 (subset randomized patients not reported) Control (usual care): n = 50 (subset randomized not reported) Randomization method not described; no details about comparability of group (except same clinical treatment) | a) Decreased HbA1c in (I: 8.31 to 7.59, |
| [ Germany 2002 4-8 months, follow-up unknown | Secondary care. | Experimental studies (RCT): n = 43 Two conditions: Intervention: n = 27 Control (usual care): n = 16 Randomization by lots (2:1 in favor of telecare). Fairly good matching of groups | a) Decreased HbA1c (I: 8.3 to 6.9 after 4 months, n = 27; to 7.1 after 8 months, n = 11; C: 8.0 to 7.0 after 4 months, n = 16, to 6.8 after 8 months, n = 10). NSD between groups. |
| [ Netherlands 1999 12 months, follow-up unknown | Primary/secondary care. | Quasi-experimental studies: n = 275 Two conditions: Intervention: n = 215 Control (usual care): n = 60 Intervention group consisted of patients from GPs with highest number of referred patients. Average age in intervention group higher; fewer type 1 patients than control group | a) Decreased HbA1c (I: 7.0 to 6.8, |
| [ United States 2002 12 months, follow-up unknown | Secondary care. | Controlled observational studies (cohort studies): n = 338 Two conditions: Intervention: n = 169 Control: n = 169 (cohort) Cohort representative of the general population in terms of ethnicity | b) Mean improvement in mental component (SF-12) after 6 months in I ( |
| [ Denmark 2006 6 months, follow-up unknown | Integrated care. | Observational studies without control group (case series): n = 13 Three conditions: Patients: n = 3 Health care professionals: n = 5 Health care professionals: n = 5 (focus group) | c) Patients experienced greater confidence and a more personal report with staff after 6 months using the system. Email facilitated a dialogue between patient and diabetes team. |
| [ United Kingdom 2005 9 months, follow-up unknown | Secondary care. | Experimental studies (RCT): n = 93 Two conditions: Intervention: n = 47 (Web-based graphical analysis, nurse initiated support) Control (real-time graphical phone-based): n = 46 Randomization (computer program); gender and psychiatric scores evenly distributed between the randomized groups | a) Decreased HbA1c (I: 9.2 to 8.6 after 9 months, |
| [ Spain 2004 9 months, follow-up unknown | Care setting not specified. | Observational studies without control group (case series): n = 172 Two conditions: Case study: n = 12 Questionnaire: n = 160 (135 non-diabetic students, 25 diabetic patients) | d) Patients were satisfied with the continuity and self-efficacy of care; lack of time was a drawback for 38%; 75% expressed a preference for sending data via a cellular phone (SMS). |
| [ Spain 2004 8 months, follow-up unknown | Care setting not specified. | Observational studies without control group (case series): n = 23 One condition | e) SMS provided a simple, fast, efficient, and low-cost adjunct to the medical management of diabetes at a distance. Particularly useful for age groups (elderly, teenagers) that are known to have difficulty in controlling diabetes well. |
| [ France 2006 6 months, follow-up unknown | Secondary care. | Experimental studies (RCT): n = 100 Two conditions: Intervention: n = 50 Control (usual care): n = 50 Randomization via computer-generated sequence using block randomization with stratification by age Comparable intervention and control groups (age, gender, HbA1c, frequency of SBGM, type of insulin therapy program) | a) Decreased HbA1c (I: 9.3 to 9.27, |
| [ Spain 2002 12 months, follow-up expected | Secondary care. | Quasi-experimental studies: n = 10 Two conditions: Intervention: n = 5 Control: n = 5 (cross-over design, switch half way through the trial) Both groups comparable concerning intervention time and inclusion criteria (inadequate metabolic control, DM duration greater than 5 years) | a) Decreased HbA1c (I: 8.4 to 7.9, |
| [ United States 2002 3 months, follow-up unknown | Primary care. | Quasi-experimental studies: n = 65 Two conditions: Intervention: n = 30 Control (usual care): n = 35 Intervention: patients had a recent change made to their therapy to lower blood glucose levels Control: remaining patients of the 65 Comparable HbA1c at baseline in two groups | a) Decreased HbA1c (I: 10.0 to 8.2; |
| [ Spain 2006 12 months, follow-up unknown | Secondary care. | Experimental studies (RCT): n = 30 Two conditions: Intervention: n = 18 Control (usual care): n = 15 Randomization via random variable generator; baseline data (HbA1c, BMI, weight, insulin, DM) and characteristics (age, gender, daily activities) comparable in two groups | a) Decreased HbA1c (I: 8.4 to 7.6; C: 8.9 to 7.6, after 12 months); NSD between groups. |
| [ South Korea 2006 12 weeks, follow-up unknown | Tertiary care. | Observational studies without control group (before-and-after design): n = 42 One condition | a) Patients had a mean decrease of 28.6 mg/dL in fasting plasma glucose ( |
| [ Italy 2006 56 weeks, follow-up unknown | Care setting not specified. | Experimental studies (RCT): n = 56 Two conditions: Intervention: n = 30 Control (usual care): n = 26 No randomization details; both groups comparable (age, treatment) | a) Location 1 decreased HbA1c (I: 8.52 to 8.30, |
| [ United States 2005 At least 24 months, follow-up unknown | Primary care setting. | Observational studies without control group (case series): n = 74 Four conditions: Patients: n = 44 Caregivers: n = 6 Case managers: n = 6 School nurses: n = 18 | c) Improved patient-caregiver communication for patients in a remote area. Use of website by nurses increased substantially when it was approved for 3 contact hours of continuing education. |
| [ Australia 2002 6 weeks, no follow-up | Care setting not specified. | Expert opinion based on consensus: n = 5 (1 caregiver, 3 diabetic patients, 1 expert) One condition | e) LifeMasters appeared successful in integrating the health care provider in diabetes management; myDiabetes is effective in providing a communication channel for community creation. LifeMasters appeared a more complete system than myDiabetes (monitoring, personalization, communication, information, technology). |
| [ United States 3 months, follow-up unknown | Primary care. | Experimental studies (RCT): n = 133 Four conditions: Information only group: n = 33 Peer support group: n = 30 Personal self-management coach condition: n = 37 Combined condition of the three above: n = 33 Randomization by presence or absence of each of the components (peer support, personalized self-management); groups comparable (gender, education, age, years diagnosed) | a) Decreased HbA1c in PSMCC (I: 7.75 to 7.73), in PSC (I: 7.64 to 7.59), in CC (I: 7.46 to 7.28). HbA1c increased in C (7.20 to 7.37 after 3 months) |
| [ United States 2005 12 months, follow-up unknown | Primary care. | Experimental studies (RCT): n = 104 Two conditions: Intervention: n = 52 Control (usual care): n = 52 No randomization details; both groups comparable (age, gender, education, metabolic values) | a) Significant decrease in HbA1c in I and C ( |
| [ United States 2004 3 months, follow-up unknown | Primary care. | Observational studies without control group (before-and-after design): n = 9 One condition | c) If expectations were not met, participants felt their concerns were less valued, and they felt more isolated from their caregiver. |
| [ Netherlands 2001 duration not specified, follow-up unknown | Primary/secondary care. | Observational studies without control group (case series): n = 594 Three conditions: Patients treated in project: n = 336 Patients treated by GP: n = 225 Patients treated in outpatient clinic: n = 33 | a) Decreased HbA1c in UDP (7.8 to 6.8, |
| [ China 2001 12 weeks, follow-up unknown | Secondary care. | Quasi-experimental studies: n = 19 Two conditions: Intervention: n = 10 Control: n = 9 Each group used the DMS for 3 months; served as the control group for another 3 months (cross-over design); comparable groups | a) Decreased HbA1c (I: 8.56 to 7.55 after treatment, to 7.84 at end of 12-week project; C: 8.81 to 8.76 after treatment, to 8.40 after end of 12-week project). Mean difference was 0.825 ( |
* a) clinical values, b) quality of life, c) interaction, d) self-care, e) usability of technology, f) cost reduction, g) transparency of guidelines, h) equity (availability of health care to everyone)
BG, blood glucose; BGL, blood glucose levels; BMI, body mass index; C, control group; CC, combined condition; DM, diabetes mellitus; DMS, diabetes monitoring system; GP, general practitioner; I, intervention; IOC, information only condition; M, mean; NS, not statistically significant; NSD; not statistically significant difference, PSC, peer support condition; PSMCC, personalized self-management coach condition; SBGM, self blood glucose monitoring; SMS, Short Message Service; TSQ, Telemedicine Satisfaction Questionnaire; UDP, Utrecht Diabetes Project; WHO, World Health Organization
Overview of videoconferencing and combined interventions
| Reference, Country, Year, and Duration of Intervention | Care Setting and Intervention | Study Design, Inclusion Criteria, and Data Gathering Methods | Reported Findings (Improvements) |
| [ Austria 2002 12 months, follow-up unknown | Primary/secondary care. | Observational studies without control group (before-and-after study): n = 154 One condition | a) Decreased HbA1c (8.1 to 7.8, |
| [ China 2005 8 weeks, no follow-up | Secondary care. | Observational studies without control group (before-and-after study): n = 22 One condition | a) Reduction in total calorie intake (energy: |
| [ Norway 2005 duration not specified, follow-up unknown | Secondary care. | Observational studies without control group (case series): n = 20 Two conditions: Workshops: n = 15 Pilot test: n = 5 | e) Staff and patients found equipment easy to use. |
| [ United States 2001 24 months, follow-up unknown | Primary care. | Experimental studies (RCT): n = 171 Two conditions: Intervention (1 video visit, 1 home visit, 1 video visit): n = 86 Control (skilled nursing home visits only): n = 85 No randomization details; groups comparable (gender, average age, mean diabetes severity score, mean number of comorbidities) | f) Cost savings without compromising quality; videoconferencing has the potential to provide the same number of patient encounters at lower costs; financial benefit increases as the duration of the patient care episode increases. |
| [ United States 2003 3 months, in case of success, follow-up | Secondary care. | Observational studies without control group (case series): n = 5 Three conditions: Telephone intervention: n = 3 Videophone intervention: n = 1 Email intervention: n = 1 | a) Decrease of HbA1c (for each child: from 9.7 to 8.5; from 8.7 to 7.1; from 13 to 6.1, from 10.2 to 9.4; from 10.9 to 7.9, after 3 months). |
| [ Canada 2002 3 months, follow-up unknown | Secondary care. | Observational studies without control group (case series): n = 25 Four conditions: Patient group: n = 8 Nurse group: n = 13 Physicians: n = 7 Managers: n = 7 | e) Patients and managers identified a higher degree of readiness for videoconferencing in patients because of the potential to support independence in their homes and in managers because of efficiency of the system. Patients wanted to maintain their level of health but with minimum intrusiveness; caregivers were more interested in measurable clinical outcomes (blood pressure, glucose); managers focused on cost-effectiveness. |
| [ United States 2003 3 months, follow-up unknown | Primary care. | Experimental studies (RCT): n = 46 Two conditions: Intervention: n = 24 Control (education in person): n = 22 Randomization via random permuted blocks; groups comparable (age, gender, BMI, duration of diabetes) | a) Decrease in HbA1c (I: 8.7 to 7.8, |
| [ United States 2005 at least 24 months, follow-up unknown | Secondary care. | Observational studies without control group (before-and-after study): n = 44 One condition | e) Over 90% of patients and family members expressed satisfaction with videoconferencing. |
| [ Australia 2003 28 months, follow-up unknown | Secondary care. | Observational studies without control group (case series): n = 170 Three conditions: Routine consultation: n = 135 Complication consultations with 1 patient: n = 25 Education sessions: n = 10 | f) Reduced travel time for specialist hospital staff (by conducting clinics via videoconferencing), while maintaining patient contact. |
| [ United States 2000 3 months, follow-up unknown | Primary care. | Experimental studies (RCT): n = 28 Two conditions: Intervention: n = 15 Control (no information available about control group): n = 13 Randomization (stratified based on age, gender, microalbumin, creatinine, HbA1c) Comparable groups | a) Decreased HbA1c (I: 9.5 to 8.2, |
| [ United States 2004 12 months, follow-up unknown | Secondary care. | Observational studies without control group (case series): n = 60 One condition | c) Sustainability of the telediabetes program depends on a feedback system; the effectiveness of the process depends on an interactive ongoing collaboration between patient and caregiver. |
| [ United States 2004 12 weeks, follow-up unknown | Secondary care. | Quasi-experimental studies: n = 140 Two conditions: Intervention: n = 20 Control (face-to-face foot program): n = 12 Comparable groups (age, wound condition) | a) No difference in I and C in the average forefoot ulcer healing time, the percentage of ulcers healed in 12 weeks, or the adjusted healing time ratio. |
| [ China 2002 18 weeks, follow-up unknown | Primary care. | Observational studies without control group (case series): n = 41 One condition | c) Videoconferencing enabled community nurses in primary care to link with nurse specialist in diabetes center to provide diabetes education in small groups. |
| [ United States 2005 24 months, follow-up unknown | Primary care. | Observational studies without control group (before-and-after study): n = 445 One condition | b) Significant improvement in health-related quality of life during 1 year (role-physical functioning: |
| [ United States 2005 24 months, follow-up unknown | Primary care. | Quasi-experimental studies: n = 297 Two conditions (two different monitoring intensities): Weekly monitoring, intensively monitored: n = 197 Daily monitoring, less intensively: n = 100 In weekly monitored group, patients were younger; in daily program, more patients were married; both groups comparable in clinical and sociodemographic characteristics | a) Decreased HbA1c in I (weekly monitoring, from 8.3 to 8.1, |
| [ United States 2005 12 months, follow-up unknown | Primary care. | Controlled observational studies (cohort studies): n = 800 Two conditions: Intervention: n = 400 Control (no intervention): n = 400 Propensity scores were used to improve the match between I and C. A difference-in-differences approach used to measure the effects of the intervention on service use | f) Significant difference between I and C in need-based primary care visits, increasing in I (7.6%) and decreasing in C (12%) ( |
| [ United States 2005 5 months, follow-up unknown | Primary care. | Observational studies without control group (case series): n = 5 One condition | e) Technology-related problems (telecommunication, connectivity) were the primary cause of installation difficulties (in patients’ homes). Patient education and training are the most critical success factors. Patient education and training accounted for two thirds of the in-home time for installation of equipment. Nurse installers are patient-centric rather than technology-centric. |
* a) clinical values, b) quality of life, c) interaction, d) self-care, e) usability of technology, f) cost reduction, g) transparency of guidelines, h) equity (availability of health care to everyone)
BMI, body mass index; C, control group; DM, diabetes mellitus; I, intervention; NS, statistically not significant; NSD, not statistically significant difference; TSQ, Telemedicine Satisfaction Questionnaire
Randomized controlled trials with HbA1c data (see Multimedia Appendix for full tables containing inclusion criteria and data gathering methods)
| Study | Trial Duration (months) | Intervention | Control | Quality Score [ | ||||
| N | Baseline and Follow-Up Values ± SD | Mean Difference ± SD | N | Baseline and Follow-Up Values ± SD | Mean Difference ± SD | |||
| Biermann [ | 4 | 27 | 8.3 ± 2.3 | −1.4 ± 2.0* | 16 | 8.0 ± 2.1 | −1.0 ± 1.82 | 3 |
| McKay (a) [ | 3 | 37 | 7.75 ± 1.33 | −0.02 ± 1.38* | 33 | 7.20 ± 1.36 | 0.17 ± 1.43 | 3 |
| McKay (b) [ | 3 | 30 | 7.64 ± 1.71 | −0.06 ± 1.69* | 33 | 7.20 ± 1.36 | 0.17 ± 1.43 | 3 |
| McKay (c) [ | 3 | 33 | 7.46 ± 1.35 | −0.18 ± 1.32* | 33 | 7.20 ± 1.36 | 0.17 ± 1.43 | 3 |
| Farmer [ | 9 | 47 | 9.2 ± 1.1 | −0.62 ± 2.42‡ | 46 | 9.3 ± 1.5§ | −0.38 ± 2.36 | 2 |
| McMahon [ | 12 | 52 | 10.0 ± 0.8 | −1.6 ± 1.4 | 52 | 9.9 ± 0.8 | −1.2 ± 1.4 | 2 |
| Jansa [ | 12 | 18 | 8.4 ± 1.2 | −0.8 ± 0.74§ | 15 | 8.9 ± 1.3 | −1.3 ± 0.64 | 3 |
| Larizza [ | 12 | 15 | 8.40 ± 2.53 | −0.65 ± 2.20* | 14 | 10.15 ± 3.25 | −0.87 ± 2.90 | 2 |
*Imputation technique.
†Intervention (a) was personal self-management coach (n = 37), intervention (b) was peer support (n = 30), and intervention (c) was combined condition (n = 33).
‡Calculated using 95% CI.
§Calculated using P values provided by author.
||Precise follow-up data were not reported.
¶Data from location 2 (adults) of the study, see Table 3.
Figure 2.Comparison of changes in HbA1c control versus intervention